Testing ADRX-0405 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called ADRX-0405 in people with advanced solid tumors like prostate, stomach, or lung cancer. The goal is to see how safe it is and if it shrinks tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these cancers: advanced prostate cancer (that no longer responds to hormone therapy), stomach cancer, or non-small cell lung cancer.
- For the second part of the study, you have prostate cancer that has stopped responding to standard treatments.
- Your tumors can be measured on scans (e.g., CT, MRI), or for prostate cancer, you have other signs the doctor can track.
- You are able to take care of yourself (ECOG score 0-2, meaning you are up and about more than half the day).
- Your blood counts, liver, and kidney function are within acceptable levels.
- You have not had cancer treatment or an experimental drug in the last 2 weeks (or 5 half-lives, whichever is shorter).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called AGX101 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it can shrink tumors or slow their growth.
This trial tests a new drug called DB-1419 for people with advanced solid tumors that have not responded to other treatments. It is designed to target a protein called B7-H3 on cancer cells, and may help shrink tumors or slow their growth.
This trial tests a new drug called MDX2004 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if the drug is safe and if it helps shrink tumors.
This early study tests whether ADU-1805 is safe in people with advanced solid tumors and checks how the body processes the drug. Depending on your cancer type, it may also be looking specifically at certain cancers that have not yet received PD-(L)1 immunotherapy.
This trial tests DXC014, a new drug, in people with advanced solid tumors, including prostate cancer. It aims to see if the drug is safe and effective.
This early-phase trial tests a new drug called ASD141 for people with advanced solid tumors that no longer respond to standard treatments. The goal is to see if it is safe and how well it works against the cancer.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.